Olverembatinib
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs. (NCT05311943) | Shenzhen Second People's Hospital | 2022-07-01 |
Track Olverembatinib automatically
Every clearance here is in the API, with alerts when new ones post.